CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes (vol 74, pg 6418, 2000)

被引：0
|
作者：
Arthos, J [1 ]
Rubbert, A
Rabin, RL
Cicala, C
Machado, E
Wildt, K
Hanback, M
Steenbeke, TD
Swofford, R
Farber, JM
Fauci, AS
机构：
[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF VIROLOGY | 2000年 / 74卷 / 17期
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：8218 / 8218
页数：1
相关论文
共 50 条
  • [31] Cloning and Analysis of Sooty Mangabey Alternative Coreceptors That Support Simian Immunodeficiency Virus SIVsmm Entry Independently of CCR5
    Elliott, Sarah T. C.
    Riddick, Nadeene E.
    Francella, Nicholas
    Paiardini, Mirko
    Vanderford, Thomas H.
    Li, Bing
    Apetrei, Cristian
    Sodora, Donald L.
    Derdeyn, Cynthia A.
    Silvestri, Guido
    Collman, Ronald G.
    JOURNAL OF VIROLOGY, 2012, 86 (02) : 898 - 908
  • [32] Human Immunodeficiency Virus Type 1 Modified To Package Simian Immunodeficiency Virus Vpx Efficiently Infects Macrophages and Dendritic Cells
    Sunseri, Nicole
    O'Brien, Meagan
    Bhardwaj, Nina
    Landau, Nathaniel R.
    JOURNAL OF VIROLOGY, 2011, 85 (13) : 6263 - 6274
  • [33] Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5Δ32 and CCR5 C20S Heterozygote
    Alkhatib, Bashar
    Jabari, Mary
    Bilasy, Shymaa
    Abdul-Rahman, Husni
    Sandhu, Kamal
    Lai, Stephen
    Alkhatib, Ghalib
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (02): : 116 - 121
  • [34] The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells
    Schols, D
    De Clercq, E
    JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 2203 - 2205
  • [35] In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells
    Rossi, R.
    Lichtner, M.
    De Rosa, A.
    Sauzullo, I.
    Mengoni, F.
    Massetti, A. P.
    Mastroianni, C. M.
    Vullo, V.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (02): : 184 - 190
  • [36] Human immunodeficiency virus type 1 disease progression, CCR5 genotype, and specific immune responses
    Visco-Comandini, U
    Hultgren, C
    Brostrom, C
    Birk, M
    Kim, S
    Sallberg, M
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (04) : 463 - 466
  • [37] CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection
    Naif, HM
    Li, S
    Alali, M
    Sloane, A
    Wu, LJ
    Kelly, M
    Lynch, G
    Lloyd, A
    Cunningham, AL
    JOURNAL OF VIROLOGY, 1998, 72 (01) : 830 - 836
  • [38] TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus
    Shi, Bingjie
    Li, Juan
    Shi, Xuanling
    Jia, Wenxu
    Wen, Yi
    Hu, Xiongbing
    Zhuang, Fengfeng
    Xi, Jianzhong
    Zhang, Linqi
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (02) : 229 - 241
  • [39] Expression of CCR5, a chemokine receptor involved in human immunodeficiency virus (HIV-1) infection
    Loy, BA
    Guo, H
    Du, J
    Lear, SC
    Martin, AW
    Peiper, SC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 817 - 817
  • [40] Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5α alleles
    Ylinen, LMJ
    Keckesova, Z
    Wilson, SJ
    Ranasinghe, S
    Towers, GJ
    JOURNAL OF VIROLOGY, 2005, 79 (18) : 11580 - 11587
12345